- Research works
- 7 ▼ 51% vs 2013–17
- Citations
- 664 92.0 per fractional work
- Top-10% rate
- 12.4% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: ImmuNext (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does ImmuNext (United States) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Renal Diseases and Glomerulopathies, Cancer Immunotherapy and Biomarkers and Systemic Lupus Erythematosus Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 2 Renal Diseases and Glomerulopathies Nephrology 0 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 4 Systemic Lupus Erythematosus Research Rheumatology 0 works
- 5 CAR-T cell therapy research Oncology 0 works
- 6 Immune cells in cancer Immunology 0 works
- 7 Immune Cell Function and Interaction Immunology 0 works
- 8 Liver Diseases and Immunity Hepatology 0 works
- 9 Immune Response and Inflammation Immunology 0 works
- 10 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ImmuNext (United States)'s research output changed?
Output in 2018–2022 was 51% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lebanon
- Dartmouth–Hitchcock Medical Center
- Dartmouth Psychiatric Research Center
- Dartmouth Institute for Health Policy and Clinical Practice
- Children's Hospital at Dartmouth Hitchcock
- Adimab (United States)
- Simbex (United States)
- Woomera Therapeutics
- DoseOptics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.